Testosterone enanthateCAS# 315-37-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 315-37-7 | SDF | Download SDF |
| PubChem ID | 9416 | Appearance | Powder |
| Formula | C26H40O3 | M.Wt | 400.6 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate | ||
| SMILES | CCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C | ||
| Standard InChIKey | VOCBWIIFXDYGNZ-IXKNJLPQSA-N | ||
| Standard InChI | InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Testosterone enanthate Dilution Calculator
Testosterone enanthate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.4963 mL | 12.4813 mL | 24.9626 mL | 49.9251 mL | 62.4064 mL |
| 5 mM | 0.4993 mL | 2.4963 mL | 4.9925 mL | 9.985 mL | 12.4813 mL |
| 10 mM | 0.2496 mL | 1.2481 mL | 2.4963 mL | 4.9925 mL | 6.2406 mL |
| 50 mM | 0.0499 mL | 0.2496 mL | 0.4993 mL | 0.9985 mL | 1.2481 mL |
| 100 mM | 0.025 mL | 0.1248 mL | 0.2496 mL | 0.4993 mL | 0.6241 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Allopurinol
Catalog No.:BCC3720
CAS No.:315-30-0
- Crotaline
Catalog No.:BCN4983
CAS No.:315-22-0
- Sunifiram
Catalog No.:BCC4167
CAS No.:314728-85-3
- 6-Methoxysalicylic Acid
Catalog No.:BCC8288
CAS No.:3147-64-6
- Mebendazole
Catalog No.:BCC9016
CAS No.:31431-39-7
- 4-Amino-3-nitrobenzophenone
Catalog No.:BCC8682
CAS No.:31431-19-3
- Nocodazole
Catalog No.:BCC3826
CAS No.:31430-18-9
- Isotachioside
Catalog No.:BCN5230
CAS No.:31427-08-4
- IU1
Catalog No.:BCC2086
CAS No.:314245-33-5
- BPTES
Catalog No.:BCC6506
CAS No.:314045-39-1
- (R)-(-)-Apomorphine hydrochloride
Catalog No.:BCC7250
CAS No.:314-19-2
- Evans Blue tetrasodium salt
Catalog No.:BCC6815
CAS No.:314-13-6
- Acetylheliosupine
Catalog No.:BCN1981
CAS No.:31514-30-4
- PAC-1
Catalog No.:BCC3600
CAS No.:315183-21-2
- Ifflaiamine
Catalog No.:BCN7061
CAS No.:31520-95-3
- Sutherlandin trans-p-coumarate
Catalog No.:BCN5231
CAS No.:315236-68-1
- Isobavachin
Catalog No.:BCN5232
CAS No.:31524-62-6
- 5-Hydroxyseselin
Catalog No.:BCN3428
CAS No.:31525-75-4
- O-Nornuciferine
Catalog No.:BCN7074
CAS No.:3153-55-7
- Matsukaze-lactone
Catalog No.:BCN7580
CAS No.:3153-73-9
- 1,18-Octadecanediol
Catalog No.:BCN5233
CAS No.:3155-43-9
- Kavain
Catalog No.:BCN8295
CAS No.:3155-48-4
- TC-DAPK 6
Catalog No.:BCC1989
CAS No.:315694-89-4
- STF-62247
Catalog No.:BCC4960
CAS No.:315702-99-9
Ovary stereological features and serum biochemical factors following induction of polycystic ovary syndrome with testosterone enanthate in mice: An experimental study.[Pubmed:29942935]
Int J Reprod Biomed (Yazd). 2018 Apr;16(4):267-274.
Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder featured by insulin resistance and hyperandrogenism. Testosterone enanthate can induce PCOS in mice models. Objective: We investigated the ovary stereological features along with the oxidative stress and inflammatory factors in mice following PCOS induction using Testosterone enanthate. Materials and Methods: Twelve female NMRI mice (3 wk old) were divided into 2 groups (n=6/each): Control and PCOS. PCOS was induced through daily injections of Testosterone enanthate (1 mg/100g subcutaneous s.c for 5 wk). Finally, ovaries were studied stereologically. The serum levels of the follicle-stimulating hormone, luteinizing hormone, testosterone, interleukin-6, and tumor necrosis factor-alpha were measured using ELISA kit. Serum levels of Malondialdehyde and the antioxidant capacity were measured relatively using thiobarbituric acid and ferric reducing antioxidant power assay. Results: The mean total volume of ovary and the mean volume of cortex (p<0.001), volume of oocyte in the preantral (p=0.011) and antral follicle (p=0.015), thickness of zona pellucida (p=0.016), the number of antral follicles (p=0.012), the serum levels of follicle-stimulating hormone (p<0.001) and the antioxidant capacity (p=0.020) reduced significantly in the PCOS group compared to the control. The number of primary (p=0.017) and preantral (p=0.006) follicles and the serum levels of testosterone (p<0.001), Luteinizing hormone (p=0.002), Malondialdehyde, Interleukin 6 and Tumor necrosis factor-alpha (p<0.001) showed a significant increase in the PCOS group compared to the control. Conclusion: Testosterone enanthate induced PCOS causes stereological features in the ovary, increases the oxidative stress and inflammatory markers in mice.
